Background illustration for clinical trials search

Paid Clinical Trials Sandy Springs

Discover 1,672 paid clinical trials in Sandy Springs, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

for
Breast Cancer
Location: Atlanta GA, Tampa FL, St Louis MO,
Sponsor: Regor Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT05304962

Phase 1, Recruiting

Treatment With Endovascular Intervention for STroke Patients With Existing Disability

for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Atlanta GA, Birmingham AL, Nashville TN, Louisville KY,
Sponsor: University of Cincinnati

Sex: All

Age: 18+

Code: NCT05911568

Recruiting

Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Atlanta GA, Chapel Hill NC, Columbus OH, St Louis MO,
Sponsor: Corvus Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06561048

Phase 3, Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for
Superficial Bladder Cancer,
Location: Atlanta GA, Augusta GA, Birmingham AL, Nashville TN,
Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase 1, Phase 2, Recruiting

Breath Test for Biomarkers in Humans Receiving Total Body Irradiation

for
Radiation Injury
Location: Atlanta GA, New York NY, Hackensack NJ
Sponsor: Menssana Research, Inc.

Sex: All

Age: 18+

Code: NCT02152722

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants

for
Premature Birth
Location: Atlanta GA
Sponsor: Thrive Neuromedical, LLC

Sex: All

Age: 0

Code: NCT06063122

Recruiting

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

for
Parkinson Disease, Parkinson, Idiopathic Parkinson Disease,
Location: Atlanta GA, Augusta GA, Nashville TN, Charleston SC,
Sponsor: Neuron23 Inc.

Sex: All

Age: 40 - 70+

Code: NCT06680830

Phase 2, Recruiting

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Intermediate Risk Non-Muscle Invasive Bladder Cancer
Location: Atlanta GA, Lexington KY, Jacksonville FL,
Sponsor: Ferring Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06510374

Phase 3, Recruiting

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

for
Clonal Mast Cell Disease, KIT D816V Mutation,
Location: Atlanta GA, Birmingham AL, Charleston SC,
Sponsor: Blueprint Medicines Corporation

Sex: All

Age: 18+

Code: NCT07143669

Recruiting

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

for
Peripartum Cardiomyopathy, Postpartum
Location: Atlanta GA, Birmingham AL, Nashville TN, Charlotte NC,
Sponsor: Dennis M. McNamara, MD, MS

Sex: Female

Age: 18+

Code: NCT05180773

Recruiting

SC2i Tissue and Data Repository Protocol

for
Critical Illness
Location: Atlanta GA, Durham NC, Bethesda MD
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Sex: All

Age: 18+

Code: NCT02182180

Recruiting

Von Willebrand Factor in Pregnancy (VIP) Study

for
Von Willebrand Diseases
Location: Atlanta GA, Nashville TN, New Orleans LA, Peoria IL,
Sponsor: University of Washington

Sex: Female

Age: 18+

Code: NCT04146376

Recruiting

Use of Force Feedback Instruments With the da Vinci Surgical System, Model IS5000 for Mitral Valve Repair

for
Mitral Regurgitation (MR)
Location: Atlanta GA, New York NY, Spokane WA
Sponsor: Intuitive Surgical

Sex: All

Age: 22+

Code: NCT07655505

Recruiting

Tofersen in Non-SOD1 ALS

for
ALS (Amyotrophic Lateral Sclerosis)
Location: Atlanta GA, St Louis MO, Boston MA
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT07294144

Phase 2, Recruiting

DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy

for
Extrapulmonary Neuroendocrine Cancer (epNEC)
Location: Atlanta GA, Knoxville TN, Nashville TN, St Louis MO,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07544654

Phase 3, Recruiting

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

for
Extensive-stage Small-cell Lung Cancer
Location: Atlanta GA, Rock Hill SC, Lexington KY, Jacksonville FL,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07459634

Phase 2, Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

for
Squamous Cell Carcinoma, Alpha Radiation, Immunocompromised,
Location: Atlanta GA, Hollywood FL, Cooperstown NY, Gilbert AZ,
Sponsor: Alpha Tau Medical LTD.

Sex: All

Age: 18+

Code: NCT06615635

Recruiting

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

for
Chronic Graft-versus-host-disease
Location: Atlanta GA, Birmingham AL, Columbus OH, St Louis MO,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 2+

Code: NCT04710576

Phase 2, Recruiting

PREcision MEDicine In Achalasia (PREMEDIA)

for
Type I Achalasia, Type II Achalasia,
Location: Atlanta GA, Nashville TN, Charlotte NC, Gainesville FL,
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07293650

Phase 3, Recruiting

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Atlanta GA, Greenville SC, Birmingham AL, Nashville TN,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase 3, Recruiting